whether gabapentin directly contributes to dementia risk,
how dosage influences long-term outcomes,
and which patients may be most vulnerable.
💡 Final Thoughts
The study does not mean that everyone taking gabapentin will develop dementia.
But it does reinforce an important principle in medicine: every treatment carries potential benefits and risks.
For patients living with chronic pain, informed decision-making and regular medical follow-up remain essential.
Awareness, monitoring, and open conversations with healthcare providers may help patients make safer long-term choices while still managing pain effectively.
This article is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment.
